Immune Health Supplements Market to Hit $31.50 bn by 2028; High Demand for Non-GMO and Organic Products to Bolster Growth

The global immune health supplements market size is projected to reach USD 31.50 billion by 2028. This information is provided by Fortune Business Insights™, in a new study, titled, “Immune Health Supplements Market Size, Share & COVID-19 Impact Analysis, By Ingredient Type (Vitamins, Minerals, Herbal Botanical Extracts, Probiotics, Amino Acids, Omega 3-fatty acids, Others), By Form (Soft Gels/Capsules, Tablets, Powder, Liquids, and Others), By Source Type (Plant Based, Animal Based), By Distribution Channel (Pharmacies and Drug Stores, Hypermarket/Supermarket, Online Stores, Specialty Store, Others) and Regional Forecast, 2021-2028.” The study further mentions that the market stood at USD 18.22 billion in 2020. However, it is set to exhibit a CAGR of 6.6% during the forecast period between 2021 to 2028.

The high demand for non-GMO and organic ingredients is set to compel manufacturers to develop state-of-the-art products. Also, the outbreak of the COVID-19 pandemic is set to transform the views of wellbeing by consumers. They are currently striving to prevent transmission of this deadly virus by taking various immune health supplements.

Royal DSM Acquires Glycom A/S to Expand its Product Offerings

In April 2020, Royal DSM, a renowned provider of nutritional products headquartered in the Netherlands, acquired Glycom A/S. The latter is considered to be one of the leading suppliers of Human Milk Oligosaccharides (HMO) in the world. The acquisition involved an investment of €765 million. It would enable the company to broaden its pre-existing offerings. The company will now be able to fulfil various medical nutrition needs, including pet food, food & beverage applications, and irritable bowel syndrome.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/immune-health-supplements-market-103319

Increasing Prevalence of Infectious Diseases to Propel Growth

Manufacturers operating in the market are constantly trying to develop their products. At the same time, they are also broadening their businesses to get hold of new growth opportunities. The increasing prevalence of infectious diseases across the globe is also spurring the demand for these supplements. Additionally, surging usage of new and traditional ingredients for the manufacturing of these supplements would accelerate the immune health supplements market growth in the near future.

However, immune health supplements do not go through quality checks by the U.S. Food and Drug Administration (FDA). Hence, their actual effects are unknown. The packaging also does not provide any prescribed pill size nor does it mention the potential health effects. These factors are expected to obstruct growth.

Enhancement of Portfolios & Expansion of Presence — Vital Strategies of Key Players

The market is consolidated in nature on account of the presence of a large number of manufacturers, such as BioGaia, Herbalife Nutrition, Bayer AG, and others. They are presently focusing on improving their distribution networks and broadening their product lines to gain more shares. Several start-ups are also taking funds from renowned investors to expand their geographic footprint.

Fortune Business Insights™ lists out prominent immune health supplements manufacturers present in the global market. They are:

• Herbalife Nutrition (California, United States)


• Nutramax Laboratories (Maryland, United States)


• BioGaia (Stockholm, Sweden)


• Blackmores Limited (New South Wales, Australia)


• Glanbia, Plc (Kilkenny, Ireland)


• Royal DSM (Heerlen, Netherlands)


• Alticor Inc. (Amway) (Michigan, United States)


• USANA Health Sciences (Utah, United States)


• Bayer AG (Leverkusen, Germany)


• NOW Foods (Illinois, United States)


• Pfizer (New York, United States)


• Other key market players

A Notable Industry Development-

• April 2020: Mumbai-based Esperer Onco Nutrition Pvt. Ltd. rose funding from Zenfold Ventures. According to one of the officials, this fund will help the company to broaden its geographical presence in the European and the U.S. markets. It would also allow the company to hire notable people in finance, supply chain, and marketing.

Further Report Findings-

• North America earned USD 6.58 billion in 2020 in terms of revenue and it is anticipated to remain at the forefront in the near future. The increasing awareness about health and wellness and the surging cases of diabetes and obesity are likely to contribute to this growth.


• In Europe, the market is expected to grow considerably backed by the increasing prevalence of chronic diseases and rising geriatric population. Also, investments by renowned companies to develop new products would aid growth.


• By the source type, the market is bifurcated into plant-based and animal-based. Out of these, the plant-based segment is set to generate the largest immune health supplements market share in the forthcoming years. This growth is attributable to the increasing adoption of the vegan diet.

The global market can be segmented in the following way: